Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 14Unknown 3Terminated 3Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma 8Stomach Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms 7Neoplasms 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Carcinoma, Hepatocellular 5Recurrence 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Thyroid Neoplasms 3Nasopharyngeal Carcinoma 3Melanoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Glioma 3Glioblastoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Osteosarcoma 2Mouth Neoplasms 2Hyperthermia 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2

Interventions

Temozolomide 10Specimen Handling 6Radiotherapy 6Magnetic Resonance Spectroscopy 6pembrolizumab 3Bevacizumab 3trametinib 2Surgical Procedures, Operative 2Radiation 2Magnetic Resonance Imaging 2Leukapheresis 2Genetic Therapy 2Fluorodeoxyglucose F18 2Biopsy 2vorasidenib 1trastuzumab deruxtecan 1ribociclib 1regorafenib 1olutasidenib 1mirdametinib 1lorlatinib 1dabrafenib 1apixaban 1aflibercept 1abexinostat 1Vinblastine 1Tretinoin 1Therapies, Investigational 1Restraint, Physical 1Re-Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Astrocytoma × Surgical Procedures, Operative × Clear all
NCT07301268 2026-04-08

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Mayo Clinic

Phase 2 Recruiting
36 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

NCT07089641 2026-04-07

ERAS801-SARG

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
10 enrolled
CNS

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡